Financing

Revolution Medicines, Inc.·Cash Flow Statement·9 metrics

Breakdown

Loading...

Metrics

Proceeds from warrant exercises

Cash And Cash Equivalents And Restricted Cash Acquired In Connection With Eqrx Acquisition Net Of Transaction Costs

Payments Of Deferred Offering Costs

Proceeds From Issuance Of Common Stock From At The Market Offering

Proceeds from issuance of common stock relating to employee stock plans

Net cash from financing activities

Proceeds from issuance of warrants

Proceeds from issuance of common stock

Taxes paid for net share settlement